Javascript is disabled or is not supported by your browser. Please upgrade your browser or enable Javascript to navigate the interface properly.

Braidwell

Latest statistics and disclosures from Braidwell's latest quarterly 13F-HR filing:

Top 5 stock holdings are Guardant Health, Bridgebio Pharma, Ascendis Pharma A/s, Exact Sciences Corp note 0.375% 3/0, Novocure, and represent 25.67% of Braidwell's stock portfolio.
Added to shares of these 10 stocks: Tandem Diabetes Care (+$67M), ARGX (+$58M), PEN (+$32M), TRML (+$24M), Nuvasive (+$18M), INSP (+$17M), KRYS (+$15M), Insmed Inc convertible security (+$13M), LNTH (+$13M), GPCR (+$11M).
Started 7 new stock positions in GPCR, ARGX, SYRE, DNLI, Cutera, Tandem Diabetes Care, TRML.
Reduced shares in these 10 stocks: Nanostring Technologies (-$106M), Nevro Corp (-$102M), BSX (-$62M), Ionis Pharmaceuticals (-$50M), NTRA (-$45M), MRUS (-$42M), GKOS (-$36M), DCPH (-$35M), , NBIX (-$33M).
Sold out of its positions in ALXO, AGEN, ANAB, AXNX, BCYC, BSX, DHR, ETNB, ENTA, INCY. Integra Lifesciences Hldgs C, ISRG, IRWD, NTRA, Nevro Corp, PRCT, PTGX, Rayzebio, REPL, Seagen, SKIN.
Braidwell was a net seller of stock by $-692M.
Braidwell has $2.7B in assets under management (AUM), dropping by -13.96%.
Central Index Key (CIK): 0001920938

Tip: Access up to 7 years of quarterly data

Positions held by Braidwell consolidated in one spreadsheet with up to 7 years of data

Download as csv

Download as Excel

Portfolio Holdings for Braidwell

Braidwell holds 72 positions in its portfolio as reported in the December 2023 quarterly 13F filing

Company (Ticker)	Portfolio Weight	Valued At	Change in Shares	Share Count	Share Price
Guardant Health Note 11/1 (Principal)	6.9	$189M		268M	0.70	View chart
Bridgebio Pharma Note 2.500% 3/1 (Principal)	5.1	$138M		114M	1.21	View chart
Ascendis Pharma A/s Note 2.250% 4/0 (Principal)	4.8	$130M	+2%	127M	1.03	View chart
Exact Sciences Corp Note 0.375% 3/0 (Principal)	4.5	$123M		131M	0.94	View chart
Novocure Note 11/0 (Principal)	4.3	$118M		136M	0.87	View chart
Neurocrine Biosciences (NBIX)	3.5	$94M	-26%	715k	131.76	View chart
Vaxcyte (PCVX)	3.0	$81M	-20%	1.3M	62.80	View chart
Xenon Pharmaceuticals (XENE)	2.8	$76M	-21%	1.6M	46.06	View chart
Nuvasive Note 0.375% 3/1 (Principal)	2.7	$74M	+31%	81M	0.92	View chart
Insulet Corp Note 0.375% 9/0 (Principal)	2.7	$73M	+15%	63M	1.15	View chart
Tandem Diabetes Care Note 1.500% 5/0 (Principal)	2.5	$67M	NEW	71M	0.95	View chart
Day One Biopharmaceuticals I (DAWN)	2.3	$62M	+13%	4.2M	14.60	View chart
Irhythm Technologies (IRTC)	2.2	$61M		568k	107.04	View chart
Argenx Se Sponsored Adr (ARGX)	2.1	$58M	NEW	153k	380.43	View chart
Bridgebio Pharma Note 2.250% 2/0 (Principal)	2.1	$57M		67M	0.85	View chart
Insmed Note 1.750% 1/1 (Principal)	2.1	$56M	+31%	52M	1.07	View chart
Penumbra (PEN)	2.1	$56M	+133%	223k	251.54	View chart
Sarepta Therapeutics Note 1.250% 9/1 (Principal)	1.9	$52M	+14%	51M	1.02	View chart
Neogenomics Note 0.250% 1/1 (Principal)	1.8	$50M	+4%	66M	0.77	View chart
Travere Therapeutics Note 2.500% 9/1 (Principal)	1.8	$48M		56M	0.85	View chart
Dexcom Note 0.250%11/1 (Principal)	1.7	$47M	+20%	45M	1.05	View chart
Keros Therapeutics (KROS)	1.6	$45M	-17%	1.1M	39.76	View chart
Paragon 28 (FNA)	1.5	$42M		3.4M	12.43	View chart
Immunocore Hldgs Ads (IMCR)	1.5	$42M	-32%	611k	68.32	View chart
Thermo Fisher Scientific (TMO)	1.5	$40M		76k	530.79	View chart
Align Technology (ALGN)	1.5	$40M	+16%	146k	274.00	View chart
Ironwood Pharmaceuticals Note 0.750% 6/1 (Principal)	1.4	$40M		38M	1.05	View chart
Nevro (NVRO)	1.4	$38M		1.8M	21.52	View chart
Inspire Med Sys (INSP)	1.4	$38M	+84%	185k	203.43	View chart
Orthopediatrics Corp. (KIDS)	1.3	$36M	+4%	1.1M	32.51	View chart
BioCryst Pharmaceuticals (BCRX)	1.3	$34M	+6%	5.7M	5.99	View chart
Legend Biotech Corp Sponsored Ads (LEGN)	1.2	$34M	-36%	563k	60.17	View chart
Maravai Lifesciences Hldgs I Com Cl A (MRVI)	1.2	$33M	+26%	5.0M	6.55	View chart
Karyopharm Therapeutics Note 3.000%10/1 (Principal)	1.2	$33M		66M	0.50	View chart
Lantheus Holdings Inc Common Stock Usd 0.01 (LNTH)	1.1	$31M	+71%	495k	62.00	View chart
Alphatec Hldgs Note 0.750% 8/0 (Principal)	1.0	$28M	-40%	27M	1.06	View chart
Alector (ALEC)	1.0	$27M	-18%	3.3M	7.98	View chart
Krystal Biotech (KRYS)	0.9	$24M	+153%	196k	124.06	View chart
Tourmaline Bio (TRML)	0.9	$24M	NEW	907k	26.18	View chart
Guardant Health (GH)	0.8	$21M	+10%	759k	27.05	View chart
Glaukos (GKOS)	0.7	$19M	-65%	243k	79.49	View chart
Apogee Therapeutics (APGE)	0.7	$19M	+38%	681k	27.94	View chart
Deciphera Pharmaceuticals (DCPH)	0.7	$19M	-64%	1.2M	16.13	View chart
Repligen Corporation (RGEN)	0.7	$19M	-13%	103k	179.80	View chart
Mineralys Therapeutics (MLYS)	0.6	$17M		2.0M	8.60	View chart
Ironwood Pharmaceuticals Note 1.500% 6/1 (Principal)	0.6	$17M		16M	1.09	View chart
Harrow Health (HROW)	0.6	$17M	-17%	1.5M	11.20	View chart
Amgen (AMGN)	0.6	$17M	+60%	58k	288.02	View chart
Terns Pharmaceuticals (TERN)	0.6	$15M	-18%	2.3M	6.49	View chart
Invitae Corp Note 2.000% 9/0 (Principal)	0.5	$15M		17M	0.89	View chart
Third Harmonic Bio (THRD)	0.5	$14M	-20%	1.3M	10.97	View chart
Outset Med (OM)	0.5	$13M		2.4M	5.41	View chart
Cullinan Oncology (CGEM)	0.5	$13M	-34%	1.2M	10.19	View chart
Structure Therapeutics Sponsored Ads (GPCR)	0.4	$11M	NEW	280k	40.76	View chart
Travere Therapeutics Note 2.250% 3/0 (Principal)	0.4	$11M	-40%	17M	0.66	View chart
Spyre Therapeutics Com New (SYRE)	0.4	$11M	NEW	515k	21.52	View chart
Merus N V (MRUS)	0.4	$10M	-80%	371k	27.50	View chart
Dyne Therapeutics (DYN)	0.4	$10M	-58%	756k	13.30	View chart
Pulmonx Corp (LUNG)	0.4	$10M	-20%	788k	12.75	View chart
Denali Therapeutics (DNLI)	0.4	$9.9M	NEW	462k	21.46	View chart
Rapt Therapeutics (RAPT)	0.4	$9.7M	-64%	389k	24.85	View chart
Neogenomics Note 1.250% 5/0 (Principal)	0.3	$9.4M	-64%	10M	0.94	View chart
Transmedics Group (TMDX)	0.3	$9.3M	-61%	118k	78.93	View chart
Cutera Note 2.250% 6/0 (Principal)	0.3	$8.4M	-5%	32M	0.26	View chart
Dbv Technologies S A Sponsored Adr (DBVT)	0.3	$7.5M	-35%	7.8M	0.95	View chart
Miragen Therapeutics (VRDN)	0.3	$7.0M	-81%	323k	21.78	View chart
Adaptive Biotechnologies Cor (ADPT)	0.2	$6.7M	+40%	1.4M	4.90	View chart
Cutera Note 4.000% 6/0 (Principal)	0.2	$6.5M	NEW	29M	0.23	View chart
Ionis Pharmaceuticals Note 4/0 (Principal)	0.2	$5.5M	-90%	5.2M	1.06	View chart
Hillevax (HLVX)	0.1	$3.3M	-85%	203k	16.05	View chart
Nanostring Technologies Note 2.625% 3/0 (Principal)	0.1	$2.7M	-97%	3.7M	0.75	View chart
Compass Therapeutics (CMPX)	0.0	$496k	-94%	318k	1.56	View chart

Past Filings by Braidwell

SEC 13F filings are viewable for Braidwell going back to 2022

Braidwell 2023 Q4 filed Feb. 14, 2024
Braidwell 2023 Q3 filed Nov. 14, 2023
Braidwell 2023 Q2 filed Aug. 14, 2023
Braidwell 2023 Q1 filed May 15, 2023
Braidwell 2022 Q4 filed Feb. 14, 2023

Disclaimers: stockzoa.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on stockzoa.com represent a recommendation to purchase or sell a stock. The information on this site is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall stockzoa.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content available on stockzoa.com, or relating to the use of, or inability to use, stockzoa.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.

Fund Directory: 1-9 A B C D E F G H I J K L M N O P Q R S T U V W X-Z